Retrospective study of risk factors for mortality in human avian influenza A(H7N9) cases in Zhejiang Province, China, March 2013 to June 2014

International Journal of Infectious Diseases

Volumn 39, Issue , 2015, Pages 95-101

  Cheng, Qing Lin ^a,b   Ding, Hua ^a   Sun, Zhou ^a   Kao, Qing Jun ^a   Yang, Xu Hui ^a   Huang, Ren Jie ^a   Wen, Yuan Yuan ^a   Wang, Jing ^a   Xie, Li ^a  

^a HANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

H7N9 subtype; Human; Influenza; Influenza A virus; Outcome; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE; AGED; ARTICLE; CHINA; CHRONIC DISEASE; CLINICAL FEATURE; CONFIDENCE INTERVAL; EDUCATION; FATALITY; FEMALE; HAND WASHING; HAZARD RATIO; HOUSEHOLD; HUMAN; INCIDENCE; INCOME; INCUBATION TIME; INFLUENZA A; INFLUENZA A VIRUS (H7N9); INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LUNG INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRATIFIED SAMPLE; SURVIVAL; UNIVARIATE ANALYSIS; ANIMAL; EPIDEMIOLOGY; INFLUENZA; MIDDLE AGED;

ADULT; AGED; ANIMALS; CHINA; FEMALE; HAND HYGIENE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84942786712     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.09.008     Document Type: Article

References (28)

1. Fouchier R.A., Garcia-Sastre A., Kawaoka Y., Barclay W.S., Bouvier N.M., Brown I.H., et al. Pause on avian flu transmission research. Science 2012, 335:400-401.
2. Xiong X., Coombs P.J., Martin S.R., Liu J., Xiao H., McCauley J.W., et al. Receptor binding by a ferret-transmissible H5 avian influenza virus. Nature 2013, 497:392-396.
3. Josset L., Zeng H., Kelly S.M., Tumpey T.M., Katze M.G. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. MBio 2014, 5:e01102-e1113.
4. Li Q., Zhou L., Zhou M., Chen Z., Li F., Wu H., et al. Preliminary report: epidemiology of the avian influenza A (H7N9) outbreak in China. N Engl J Med 2013, 368:1-11.
5. Gao R., Cao B., Hu Y., Feng Z., Wang D., Hu W., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368:1888-1897.
6. Chinese Center for Disease Control and Prevention. Chinese Center for Disease Control and Prevention information system, 31 Jan 2015. Beijing: 2015. Available at: (accessed February 5, 2015). http://10.249.1.170/UVSSERVER2.0/login?fromSmp=true%26fromCDC3=true%26service=http%3A%2F%2F10.249.1.170%2Fportal%2FcasAuthUser?vsite%3Dguojia.
7. Gao H.N., Lu H.Z., Cao B., Du B., Shang H., Gan J.H., et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013, 368:2277-2285.
8. Ji H., Gu Q., Chen L., Xu K., Ling X., Bao C., et al. Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province, Eastern China. PLoS One 2014, 9:e89581.
9. China National Health and Family Planning Commission. The diagnosis and treatment programs of human infections with H7N9 virus (the 2014 edition). Beijing: China National Health and Family Planning Commission, 2014. Available at: (accessed February 7, 2015). http://www.nhfpc.gov.cn/yzygj/s3593g/201401/3f69fe196ecb4cfc8a2d6d96182f8b22.shtml.
10. Chinese Center for Disease Control and Prevention. The epidemiology survey program of human infections with H7N9 virus. Beijing: Chinese Center for Disease Control and Prevention, 2013. Available at: (accessed February 7, 2015). http://www.chinacdc.cn/wasdemo/search?templet=outline.jsp%26prepage=30%26channelid=133539%26searchword=%E4%BA%BA%E6%84%9F%E6%9F%93H7N9%E7%A6%BD%E6%B5%81%E6%84%9F%E6%B5%81%E8%A1%8C%E7%97%85%E5%AD%A6%E8%B0%83%E6%9F%A5%E6%96%B9%E6%A1%88.
11. Chinese Center for Disease Control and Prevention. The plan of collection specimens and laboratory examination of human infections with H7N9 virus. Beijing: Chinese Center for Disease Control and Prevention, 2013. Available at: (accessed February 7, 2015). http://www.chinacdc.cn/wasdemo/search.
12. Boyce J.M., Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 2002, 30:S1-S46.
13. National Advisory Committee on Immunization. Statement on influenza vaccination for the 2008-2009 seasons. Can Commun Dis Rep 2008; 34:ACS-3. Available at: (accessed November 6, 2009). http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/08vol34/acs-3/index-eng.php.
14. Muthuri S.G., Myles P.R., Venkatesan S., Leonardi-Bee J., Nguyen-Van-Tam J.S. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013, 207:553-563.
15. Louie J.K., Yang S., Acosta M., Yen C., Samuel M.C., Schechter R., et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A(H1N1)pdm09. Clin Infect Dis 2012, 55:1198-1204.
16. Piralla A., Pariani E., Rovida F., Campanini G., Muzzi A., Emmi V., et al. Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic. PLoS One 2011, 6:e28332.
17. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J.D., Chau T.N.B., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Med 2006, 12:1203-1207.
18. Yu H., Cowling B.J., Feng L., Lau E.H.Y., Liao Q., Tsang T.K., et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 2013, 382:138-145.
19. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010, 59:1057. US Centers for Disease Control and Prevention (CDC).
20. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009, 302:1896-1902.
21. Kandun I.N., Tresnaningsih E., Purba W.H., Lee V., Samaan G., Harun S., et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 2008, 372:744-749.
22. World Health Organization. Influenza at human-animal interface (HAI): cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. Geneva: WHO; 2013. Available at: (accessed March 15, 2014). http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table%20archives/en/index.html.
23. Szalai A.J., McCrory M.A., Xing D., Hage F.G., Miller A., Oparil S., et al. Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models. Mediators Inflamm 2014, 2014:1-9.
24. Koenig W., Löwel H., Baumert J., Meisinger C. C-reactive protein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in Southern Germany. Circulation 2004, 109:1349-1353.
25. Ingram P.R., Inglis T., Moxon D., Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 2010, 36:528-532.
26. Falsey A.R., Walsh E.E., Francis C.W., Looney R.J., Kolassa J.E., Hall W.J., Abraham G.N. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J Infect Dis 2001, 183:995-999.
27. Wang L., Chang L.S., Lee I.K., Tang K.S., Li C.C., Eng H.L., et al. Clinical diagnosis of pandemic A (H1N1) 2009 influenza in children with negative rapid influenza diagnostic test by lymphopenia and lower C-reactive protein levels. Influenza Other Respir Viruses 2014, 8:91-98.
28. Liao Q., Cowling B.J., Lam W.W., Fielding R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS One 2011, 6:e17713.